Biotech 2050: Novel Approach to Targeted Protein Degradation, Nicki Thompson, CEO, Amphista Therapeutics

1 February 2023

Biotech 2050: Novel Approach to Targeted Protein Degradation, Nicki Thompson, CEO, Amphista Therapeutics
01 February 2023

Biotech 2050 – View full story